Cargando…

Serum Procalcitonin Levels in Newly Diagnosed Hodgkin Lymphoma: Correlation with Other Inflammatory Biomarkers

Background and Objectives: Procalcitonin (PCT) is a useful biomarker for the diagnosis of sepsis. Inflammatory markers are elevated in patients with Hodgkin lymphoma (HL), and yet ongoing infection rarely coexists at diagnosis. PCT levels might be helpful in differentiating bacterial from disease-re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Piperidou, Alexia, Zografos, Eleftherios, Vassilakopoulos, Theodoros J., Angelopoulou, Maria K., Hillas, Georgios, Pappis, Vassiliki, Boutsikas, George, Dimou, Maria, Petevi, Kyriaki, Kanellopoulos, Alexandros, Kyrtsonis, Marie-Christine, Panayiotidis, Panayiotis, Vassilakopoulos, Theodoros P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609271/ https://www.ncbi.nlm.nih.gov/pubmed/36295492 http://dx.doi.org/10.3390/medicina58101331

Ejemplares similares

P051: Serum procalcitonin levels in newly diagnosed classical Hodgkin Lymphoma (cHL): Correlation with other inflammatory biomarkers
por: Piperidou, Alexia, et al.
Publicado: (2022)

Incorporating Monoclonal Antibodies into the First-Line Treatment of Classical Hodgkin Lymphoma
por: Vassilakopoulos, Theodoros P., et al.
Publicado: (2023)

Very late relapses in Hodgkin lymphoma treated with chemotherapy with or without radiotherapy: linear pattern and distinct prognostic factors
por: Vassilakopoulos, Theodoros P., et al.
Publicado: (2022)

New Insights in the Mobilization of Hematopoietic Stem Cells in Lymphoma and Multiple Myeloma Patients
por: Angelopoulou, Maria K., et al.
Publicado: (2014)

The Role of mTOR in B Cell Lymphoid Malignancies: Biologic and Therapeutic Aspects
por: Karatrasoglou, Eleni A., et al.
Publicado: (2023)

Low Bone Mineral Density and High Bone Turnover in Patients With Non-Hodgkin's Lymphoma (NHL) Who Receive Frontline Therapy: Results of a Multicenter Prospective Study
por: Anargyrou, Konstantinos, et al.
Publicado: (2019)

Complete eradication of chronic lymphocytic leukemia with unusual skin involvement of high mitotic index after time‐limited venetoclax/obinutuzumab treatment
por: Dimou, Maria, et al.
Publicado: (2021)

Optimizing outcomes in relapsed/refractory Hodgkin lymphoma: a review of current and forthcoming therapeutic strategies
por: Vassilakopoulos, Theodoros P., et al.
Publicado: (2020)

Immunotherapy in Hodgkin Lymphoma: Present Status and Future Strategies
por: Vassilakopoulos, Theodoros P., et al.
Publicado: (2019)

Prognostic Significance of Serum Free Light Chains in Chronic Lymphocytic Leukemia
por: Sarris, Katerina, et al.
Publicado: (2013)

Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience
por: Angelopoulou, Maria K., et al.
Publicado: (2017)

Genetic and molecular mechanisms in multiple myeloma: a route to better understand disease pathogenesis and heterogeneity
por: Kyrtsonis, Marie-Christine, et al.
Publicado: (2010)

New Insights into Monoclonal B-Cell Lymphocytosis
por: Kalpadakis, Christina, et al.
Publicado: (2014)

The disease burden of chronic obstructive pulmonary disease in Greece
por: Kourlaba, Georgia, et al.
Publicado: (2016)

Poor Neutralizing Antibody Responses in 132 Patients with CLL, NHL and HL after Vaccination against SARS-CoV-2: A Prospective Study
por: Terpos, Evangelos, et al.
Publicado: (2021)

Poor Neutralizing Antibody Responses in Patients with CLL, NHL and HL after Vaccination Against Sars-Cov-2; A Prospective Study in 132 Patients
por: Terpos, Evangelos, et al.
Publicado: (2021)

Nodular Lymphocyte-Predominant Hodgkin Lymphoma in a Patient with Familial Mediterranean Fever
por: Belia, Marina, et al.
Publicado: (2022)

The direct and indirect costs of managing chronic obstructive pulmonary disease in Greece
por: Souliotis, Kyriakos, et al.
Publicado: (2017)

Immunohistochemical Analysis of IL-6, IL-8/CXCR2 Axis, (Tyr)p-STAT-3, and SOCS-3 in Lymph Nodes from Patients with Chronic Lymphocytic Leukemia: Correlation between Microvascular Characteristics and Prognostic Significance
por: Levidou, Georgia, et al.
Publicado: (2014)

P114: Very late relapses in patients with Hodgkin Lymphoma occuring ≥5 years after initial treament with chemotherapy ± radiotherapy: Treatment strategies and prognostic factors for the outcome
por: Vassilakopoulos, Theodoros P., et al.
Publicado: (2022)

TACI Mutations in Primary Antibody Deficiencies: A Nationwide Study in Greece
por: Kakkas, Ioannis, et al.
Publicado: (2021)

Direct and Indirect Costs of Asthma Management in Greece: An Expert Panel Approach
por: Souliotis, Kyriakos, et al.
Publicado: (2017)

Symptomatic ovarian involvement as the initial presentation of primary mediastinal large b-cell lymphoma
por: Piperidou, Alexia, et al.
Publicado: (2022)

Serum Soluble TACI, a BLyS Receptor, Is a Powerful Prognostic Marker of Outcome in Chronic Lymphocytic Leukemia
por: Kyrtsonis, Marie-Christine, et al.
Publicado: (2014)

Ratio of involved/uninvolved immunoglobulin quantification by Hevylite™ assay: clinical and prognostic impact in multiple myeloma
por: Koulieris, Efstathios, et al.
Publicado: (2012)

Very Early Onset of Therapy-Related Acute Myeloid Leukemia with 11q23 Rearrangement Presenting with Unusual PET Findings after R-DA-EPOCH for Primary Mediastinal Large B-Cell Lymphoma
por: Chatzidimitriou, Chrysovalantou, et al.
Publicado: (2021)

Richter's transformation as leptomeningeal infiltration in a chronic lymphocytic leukemia patient receiving venetoclax. Could blood‐brain barrier be a disease “sanctuary” during venetoclax treatment?
por: Dimou, Maria, et al.
Publicado: (2021)

Real world data on the prognostic significance of monocytopenia in myelodysplastic syndrome
por: Diamantopoulos, Panagiotis T., et al.
Publicado: (2022)

Can resistive breathing injure the lung? Implications for COPD exacerbations
por: Vassilakopoulos, Theodoros, et al.
Publicado: (2016)

Improving outcomes after autologous transplantation in relapsed/refractory Hodgkin lymphoma: a European expert perspective
por: Sureda, Anna, et al.
Publicado: (2020)

Prognostic significance of signal transducer and activator of transcription 5 and 5b expression in Epstein–Barr virus‐positive patients with chronic lymphocytic leukemia
por: Diamantopoulos, Panagiotis T., et al.
Publicado: (2016)

New Insights into Malignant B-Cell Disorders
por: Kyrtsonis, Marie-Christine, et al.
Publicado: (2015)

Extramedullary sudden blast crisis in chronic-phase chronic myeloid leukemia during first-line treatment with nilotinib
por: Angelopoulou, M K, et al.
Publicado: (2016)

P053: The cGAS-STING anti-tumor immune response pathway as a potential therapeutic target in classical Hodgkin Lymphoma (cHL)
por: Xagoraris, Ioanna, et al.
Publicado: (2022)

The Clinical and Prognostic Significance of Ribonucleotide Reductase Subunits RRM1 and RRM2 mRNA Levels in Patients with Chronic Lymphocytic Leukemia
por: Chatzidavid, Sevastianos, et al.
Publicado: (2023)

Bench-to-bedside review: Weaning failure – should we rest the respiratory muscles with controlled mechanical ventilation?
por: Vassilakopoulos, Theodoros, et al.
Publicado: (2006)

What’s new about pulmonary hyperinflation in mechanically ventilated critical patients
por: Vassilakopoulos, Theodoros, et al.
Publicado: (2020)

Tiotropium bromide exerts anti-inflammatory effects during resistive breathing, an experimental model of severe airway obstruction
por: Toumpanakis, Dimitrios, et al.
Publicado: (2017)

Clonotypic Analysis of Immunoglobulin Heavy Chain Sequences in Patients with Waldenström's Macroglobulinemia: Correlation with MYD88 L265P Somatic Mutation Status, Clinical Features, and Outcome
por: Petrikkos, Loizos, et al.
Publicado: (2014)

Tumor Size Measurements for Predicting Hodgkin’s and Non-Hodgkin’s Lymphoma Response to Treatment
por: Kallergi, Maria, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ei5h2jrcmctlo0uiku6gqmh9md